More SEC Filings
View Older Stories View Newer Stories-
Form D SE-0518 Fund II, a serie
-
Form FWP JPMorgan Chase Financial Filed by: JPMorgan Chase Financial Co. LLC
-
Form FWP JPMORGAN CHASE & CO Filed by: JPMORGAN CHASE & CO
-
Form 6-K BetterLife Pharma Inc. For: Aug 03
-
Form 424B3 Prosper Funding LLC
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B3 Prosper Funding LLC
-
Form 10-Q Bristow Group Inc. For: Jun 30
-
Form 424B3 Prosper Funding LLC
-
Form D Kindred N3T, L.P.
-
Form 424B3 Prosper Funding LLC
-
Form D CA-0609 Fund II, a serie
-
Form 424B3 Prosper Funding LLC
-
Form 424B2 CITIGROUP INC
-
Form D VE-0526 Fund II, a serie
-
Form 10-Q Atlas Energy Solutions For: Jun 30
-
Form 424B3 Prosper Funding LLC
-
Form 424B3 Prosper Funding LLC
-
Form 424B3 Prosper Funding LLC
-
Form 13F-HR 111 Capital For: Jun 30
-
Form S-3 BED BATH & BEYOND, INC.
-
Form 424B3 Biodexa Pharmaceuticals
-
Form 8-K Archrock, Inc. For: Aug 04
-
Form D Oncologic, Inc. / DE
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form D Stateless SPV VII NR, a
-
Form D PI-0419 Fund I, a series
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 424B3 Biodexa Pharmaceuticals
-
Form S-3 BED BATH & BEYOND, INC.
-
Form 424B2 BofA Finance LLC
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 8-K Twin Vee PowerCats, Co. For: Aug 04
-
Form D Monster Equities LLC
-
Form 424B3 Biodexa Pharmaceuticals
-
Form FWP BARCLAYS BANK PLC Filed by: BARCLAYS BANK PLC
-
Form FWP BARCLAYS BANK PLC Filed by: BARCLAYS BANK PLC
-
Form 424B3 Biodexa Pharmaceuticals
-
Form PRE 14A Twin Vee PowerCats, Co. For: Aug 04
-
Form D VIA equity Fund VI K/S
-
Form 497K DIMENSIONAL INVESTMENT
-
Form 6-K GrowHub Ltd For: Aug 04
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 424B3 Biodexa Pharmaceuticals
-
Form 8-A12B Roundhill ETF Trust
-
Form 424B2 BARCLAYS BANK PLC
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form D SM-0727 Fund IV, a serie
-
Form 8-K CORVEL CORP For: Aug 05
